当前位置:首页 - 行情中心 - 汇宇制药-W(688553) - 财务分析 - 现金流量表

汇宇制药-W

(688553)

  

流通市值:84.10亿  总市值:103.70亿
流通股本:3.44亿   总股本:4.24亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金576,129,500.01295,333,237.741,169,003,551.67944,767,630.14
  收到的税费返还8,318,146.46229,173.3516,557,417.0715,917,077.67
  收到其他与经营活动有关的现金77,654,836.0851,001,923.74105,921,407.0277,607,395.21
  经营活动现金流入的平衡项目000-0.01
  经营活动现金流入小计662,102,482.55346,564,334.831,291,482,375.761,038,292,103.01
  购买商品、接受劳务支付的现金196,853,160.68102,321,191.67169,507,856.83175,307,739.12
  支付给职工以及为职工支付的现金119,755,694.5169,376,372.82262,619,402.77190,599,318.58
  支付的各项税费37,432,550.417,099,91255,241,446.0372,766,748.69
  支付其他与经营活动有关的现金335,126,793.27155,204,935.33561,158,075.22437,373,564.09
  经营活动现金流出的平衡项目00.0100
  经营活动现金流出小计689,168,198.86344,002,411.831,048,526,780.85876,047,370.48
  经营活动产生的现金流量净额平衡项目00.0100
  经营活动产生的现金流量净额-27,065,716.312,561,923.01242,955,594.91162,244,732.53
二、投资活动产生的现金流量:
  收回投资收到的现金263,000,00040,000,0001,578,000,0001,181,000,000
  取得投资收益收到的现金2,703,545.941,100,496.1120,554,005.3817,163,443.58
  处置固定资产、无形资产和其他长期资产收回的现金净额20,000-98,99585,800
  投资活动现金流入小计265,723,545.9441,100,496.111,598,653,000.381,198,249,243.58
  购建固定资产、无形资产和其他长期资产支付的现金51,722,115.3538,596,312.19128,180,390.42110,797,716.01
  投资支付的现金233,000,000190,000,0001,200,015,133.84953,035,710.55
  投资活动现金流出小计284,722,115.35228,596,312.191,328,195,524.261,063,833,426.56
  投资活动产生的现金流量净额-18,998,569.41-187,495,816.08270,457,476.12134,415,817.02
三、筹资活动产生的现金流量:
  取得借款收到的现金359,146,000156,100,000385,000,000385,000,000
  收到其他与筹资活动有关的现金234,925,444.45173,203,500271,393,025.01212,833,941.68
  筹资活动现金流入小计594,071,444.45329,303,500656,393,025.01597,833,941.68
  偿还债务支付的现金325,000,000270,000,000326,500,000231,933,710
  分配股利、利润或偿付利息支付的现金193,157,388.371,885,967.5198,135,971.894,919,941.07
  支付其他与筹资活动有关的现金165,639,900115,000,000318,056,546.71237,874,782.01
  筹资活动现金流出小计683,797,288.37386,885,967.51742,692,518.51564,728,433.08
  筹资活动产生的现金流量净额-89,725,843.92-57,582,467.51-86,299,493.533,105,508.6
四、汇率变动对现金及现金等价物的影响3,959,643.3-66,510.81-
  现金及现金等价物净增加额平衡项目-0.01000
五、现金及现金等价物净增加额-131,830,486.35-242,516,360.58427,180,088.34329,766,058.15
  加:期初现金及现金等价物余额2,057,244,246.522,057,244,246.521,630,064,158.181,630,064,158.18
  期末现金及现金等价物余额平衡项目0-0.0100
  期末现金及现金等价物余额1,925,413,760.171,814,727,885.932,057,244,246.521,959,830,216.33
补充资料:
  净利润-83,595,454.15-315,897,222.3-
  资产减值准备-102,518.99-14,813,594.43-
  固定资产和投资性房地产折旧44,176,735.62-75,059,899.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧44,176,735.62-75,059,899.59-
  无形资产摊销1,113,421.18-2,261,992.82-
  长期待摊费用摊销460,881.84-921,763.68-
  处置固定资产、无形资产和其他长期资产的损失21,342.13-301,236.61-
  固定资产报废损失--843,877.22-
  公允价值变动损失146,324,714.95--239,856,212.2-
  财务费用5,248,399.9-13,302,626.07-
  投资损失-3,029,759.73--13,815,175.53-
  递延所得税-23,488,849.5-30,311,171.84-
  其中:递延所得税资产减少-20,563,569.79-29,337,709.28-
    递延所得税负债增加-2,925,279.71-973,462.56-
  存货的减少-58,215,946.64--12,876,292.81-
  经营性应收项目的减少30,501,313.61--20,265,210.39-
  经营性应付项目的增加-88,214,100.98-73,372,590.06-
  其他--1,977,617.36-
  现金的期末余额1,925,413,760.17-2,057,244,246.52-
  减:现金的期初余额2,057,244,246.52-1,630,064,158.18-
  现金及现金等价物的净增加额-131,830,486.35-427,180,088.34-
公告日期2025-08-302025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑